Alternatives to Houdini Bio

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Leveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Engineering scalable gene therapies for broader patient populations.

AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.

AI-native biotech company designing next-generation CAR T therapies for solid tumors.

Developing novel therapies to reverse aging and extend lifespan.

Advancing next-generation mRNA medicines.

Scalable, one-time curative in-vivo gene editing therapies.

Decoding the immune system to pioneer a paradigm shift in disease diagnosis and treatment.

AI-enabled technology for cell biology research and biopharma development.

Space BioTech startup developing an autonomous, high-throughput screening platform for drug discovery in microgravity.

Developing precision medicines for inflammatory and immune-mediated diseases using AI and patient sample analysis.

Advancing biopsy specimen stewardship and expanding access to precision oncology.

Developing disease-responsive advanced therapies through programmable gene control technology.

Biotechnology company defining membrane protein spatial relationships to create novel therapeutics for cancer and autoimmune diseases.

Clinical-stage biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) for cancer treatment.

Developing an automated platform for liquid biopsy sample preparation.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

A vertically-integrated procurement platform for the life sciences industry.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

BreezeBio is a genetic medicine company developing a pipeline of precision therapeutics.

A biotechnology company developing genetic therapies for rare disorders.

A nonprofit research organization leveraging AI and biotechnology to understand and treat complex diseases.

Biotechnology company developing next-generation gene therapies using a proprietary protein splicing platform.

Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.

An end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials, focusing on lung and heart disease.

AI-powered antibody discovery platform.

Developing oral small molecule medicines for immunological and chronic diseases.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

A biotechnology ecosystem company powering the future of drug discovery and development through AI-driven platforms and integrated services.

AI biologist platform accelerating preclinical drug development by integrating biological data for smarter decisions.

Unlocking industrial-scale RNA-seq for primary drug screening and toxicology.

Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

Leveraging the adaptive immune system to diagnose and treat disease.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

A biotechnology company focused on oncology drug discovery.

A biopharmaceutical company developing RNA interference (RNAi)-based medicines.

Advancing scalable microbiome-based therapeutics for severe and chronic diseases.

Platform designed to cut cell and gene therapy production costs.

Developing a new histotripsy therapeutic platform for cancer treatment.

R&D cloud platform for life sciences, enabling scientific innovation and productivity.

A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.

AI-powered spatial biology platform for precision medicine and drug development.

AI-driven digital twin of embryo development for cell-based therapies.

Clinical-stage biotech company developing transformative cytokine therapies.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

AI-powered platform for designing novel molecular structures for new medicines.